DEF: Xylem sets records, seeks ESPP approval

Xylem reported record 2025 results and asked shareholders to elect nine directors, ratify Deloitte, approve executive pay, and adopt a 2026 Employee Stock Purchase Plan ahead of its May 14, 2026 virtual annual meeting.

Summary

• Annual meeting scheduled for May 14, 2026 at 8:00 a.m. ET, virtual-only; record date March 19, 2026.
• Four proposals: elect nine directors; ratify Deloitte & Touche LLP as 2026 auditor; advisory vote on executive compensation; implement 2026 Employee Stock Purchase Plan (ESPP).
• 2025 financials: revenue $9.035B (+6% reported, +5% organic); net income margin 10.6%; adjusted EBITDA margin 22.2% (+160 bps); GAAP EPS $3.92; adjusted EPS $5.08 (+19%).
• Cash flow: operating cash flow margin 13.7%; adjusted free cash flow margin 10.2%.
• Commercial momentum: record 2025 orders >$8.9B supporting $4.6B backlog; returned $391M to shareholders via dividends.
• Evoqua integration: achieved full $140M cost synergy run-rate exiting 2025, one year ahead of three-year target.
• Portfolio: signed agreement to divest international metering business (expected close Q1 2026) to focus on higher-margin North America metering.
• Governance: independent Board Chair; 9 nominees (8 independent); 100% 2025 Board and committee attendance; director skills matrix implemented; consolidated cybersecurity and product safety oversight with the Board.
• Compensation: 2025 Say-on-Pay support 87%; CEO 2025 pay largely performance-based; AIP tied 100% to financial metrics; PSUs based on relative TSR and cumulative adjusted EPS.
• ESPP: up to 4,000,000 shares; 85% purchase price of the lower of first/last day of six‑month periods; approx. 17,000 employees eligible; Section 16 officers/senior executives excluded.
• Audit: Deloitte engagement for 2026; 2025 fees $9.504M (audit $9.165M; audit-related $0.303M; tax $0.036M).
• Sustainability: exceeded all 2025 Customer Sustainability Goals; CDP Climate Change A-List; 81% of ~22,000 colleagues volunteered ~255,000 hours; injury frequency rate 0.43 (>17% YoY improvement).

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as solidly positive: record financials, strong backlog, and early synergy delivery, complemented by portfolio focus and broad-based governance updates.

Positives

• Record 2025 revenue of $9.035B with 5% organic growth and adjusted EBITDA margin expansion to 22.2% (+160 bps).
• Adjusted EPS rose 19% to $5.08; GAAP EPS $3.92.
• Record orders >$8.9B and a robust $4.6B backlog support 2026 visibility.
• Evoqua cost synergies reached the full $140M run-rate one year ahead of plan.
• Portfolio optimization under way with agreed sale of international metering business (expected close Q1 2026).
• Strong cash generation: operating cash flow margin 13.7%; adjusted free cash flow margin 10.2%.
• Shareholder returns: $391M dividends in 2025.
• Governance and oversight strengthened (skills matrix; centralized cybersecurity oversight; 100% Board/committee attendance).
• ESPP broadens employee ownership while excluding Section 16 officers, aligning culture with shareholder value.

Negatives

• Proxy notes forward‑looking uncertainties and references broader risk factors (legal/regulatory changes, business conditions) that could affect results.
• Free cash flow margin (10.2%) and operating cash flow margin (13.7%) trail EBITDA margin, signaling ongoing working capital and capex needs.
• Audit fees increased to $9.504M in 2025 (from $9.074M in 2024) on inflation and incremental statutory audits.

Risks

• Forward-looking statements subject to significant risks and uncertainties, including changes in legal and regulatory requirements, business conditions, and stakeholder expectations.
• Cybersecurity and product safety risks are material focus areas under Board oversight.
• Execution risks tied to ERP implementation, 80/20 simplification initiatives, and portfolio optimization.
• Integration and synergy capture execution (post‑Evoqua) despite being ahead of schedule.
• Business continuity, disaster recovery, and crisis response risks overseen by the Nominating & Governance Committee.
• Data privacy, environmental, health, safety, security, and trade compliance risks under committee oversight.
• Market, customer, and competitive landscape risks, including pricing, supply chain, and capital deployment decisions.
• Transaction closing risk on the international metering business divestiture (expected Q1 2026).

Future Outlook

Management plans to continue margin expansion while investing in sales effectiveness, marketing, product management, innovation, and AI in 2026; execute ERP modernization and 80/20 initiatives; and complete the divestiture of the international metering business (expected Q1 2026) to enhance profitability and focus.

Management Comments

• Achieved record results in 2025, surpassing $9 billion in revenue and setting a new profitability benchmark while exceeding all 2025 customer sustainability goals ahead of schedule.
• Two years of focused transformation—sharpened purpose, simplified operating model, and 80/20 mindset—are driving performance and momentum.
• In 2026, we will continue expanding margins and invest deliberately in sales, marketing, product management, innovation, and AI to accelerate profitable growth.
• AI’s rapid adoption is raising water demand in data centers, semiconductors, and power generation; Xylem is uniquely positioned to help utilities and industrials meet this demand through smart water and reuse solutions.
• Purpose and performance are inseparable—our sustainability leadership strengthens competitive advantage and financial outcomes.

Industry Context

StockSavvy.ai notes that Xylem’s positioning at the intersection of municipal and industrial water is leveraged by secular trends: AI-driven data center expansion, semiconductor capacity growth, and grid modernization—all intensifying water and resilience needs. Against peers in flow control and water technology (e.g., Pentair, Flowserve, Ecolab), Xylem’s record backlog, early synergy capture, and portfolio focus signal competitive momentum.

Comparison to Industry Standards

• Margins: Xylem’s 2025 adjusted EBITDA margin of 22.2% is above many traditional flow control peers (e.g., Flowserve historically mid‑teens) but below higher-mix industrial tech peers (e.g., IDEX often high‑20s), reflecting continued mix and efficiency opportunities.
• Growth: Organic revenue growth of 5% in 2025 tracks mid-single-digit norms for diversified industrials; order strength and backlog ($4.6B) compare favorably to peers with similar municipal/industrial exposure (e.g., Pentair’s residential cyclicality).
• Cash conversion: Adjusted FCF margin of 10.2% is in line with many multi‑industry peers, with room to approach best-in-class industrials (>12–15%) through working capital and ERP benefits.
• Synergies: Achieving the $140M Evoqua synergy run‑rate one year early compares well with integration timelines seen in sector transactions (e.g., multi‑year synergy ramps at Fortive/IDEX portfolio deals).

Corporate Governance

Related Party Transactions

• No related party transactions requiring disclosure since January 1, 2025.

Stakeholder Impact

• Shareholders: Record financial performance, $391M dividends, enhanced governance, and clear voting agenda.
• Employees: ESPP (if approved) expands ownership to ~17,000 eligible employees; leadership development and AI training initiatives underway.
• Customers: Continued investment in innovation and smart water solutions; strong backlog supports delivery.
• Suppliers: Ongoing 80/20 simplification and ERP modernization may alter demand planning and process expectations.
• Communities: Sustained sustainability and volunteer commitments (255,000 hours in 2025) and CDP A‑List recognition.
• Creditors: Strong cash generation and early synergy capture support credit profile; Deloitte reappointed as auditor.

Next Steps

• Hold the virtual Annual Meeting on May 14, 2026 to vote on four proposals.
• If approved, implement the 2026 Employee Stock Purchase Plan with six‑month offering periods.
• Complete the divestiture of the international metering business (expected Q1 2026).
• Advance ERP program, 80/20 initiatives, and AI adoption to drive profitable growth.
• Engage new Deloitte lead audit partner for the 2026–2030 cycle.

Key Dates

Recommendation

While performance metrics and execution are strong (record revenue, margin expansion, early synergies, robust backlog), the proxy primarily formalizes already disclosed results and governance items. Without new guidance or valuation context, a prudent stance is to hold pending execution on 2026 initiatives and portfolio actions.

Keywords

Xylem, water technology, Evoqua synergies, Employee Stock Purchase Plan, proxy statement, annual meeting, adjusted EBITDA, free cash flow, smart water infrastructure, metering divestiture, Deloitte audit, say-on-pay, relative TSR, AI and data centers, utilities, industrial water, sustainability, CDP A-List, backlog